Gargi Patel - AstraZeneca (United Kingdom)

基本信息

浏览量：30

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 42 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer

Aditya Bardia,X. Hu,Rebecca Dent,Kan Yonemori,Carlos H. Barrios, Joyce A. O'Shaughnessy,Hans Wildiers,Jean-Yves Pierga,Qingyuan Zhang,Cristina Saura,Laura Biganzoli,Joohyuk Sohn,Seock-Ah Im,Christelle Levy,William Jacot, Natasha Begbie, Jun Ke,Gargi Patel,Giuseppe Curigliano

NEW ENGLAND JOURNAL OF MEDICINEno. 22 (2024): 2110-2122

引用10浏览0WOS引用

Trastuzumab Deruxtecan (T-Dxd) Vs Physician’s Choice of Chemotherapy (TPC) in Patients (pts) with Hormone Receptor-Positive (HR+), Human Epidermal Growth Factor Receptor 2 (Her2)-Low or HER2-ultralow Metastatic Breast Cancer (mbc) with Prior Endocrine Therapy (ET): Primary Results from DESTINY-Breast06 (DB-06)

Giuseppe Curigliano,Xichun Hu,Rebecca Alexandra Dent,Kan Yonemori,Carlos H. Barrios Sr,Joyce O'Shaughnessy,Hans Wildiers,Qingyuan Zhang,Seock-Ah Im,Cristina Saura,Laura Biganzoli,Joohyuk Sohn,Christelle Levy,William Jacot, Natasha Begbie,Jun Ke,Gargi Surendra Patel,Aditya Bardia

JOURNAL OF CLINICAL ONCOLOGYno. 17_SUPPL (2024): LBA1000-LBA1000

引用16浏览0引用

Abstract PD16-02: Factors Associated with Receipt of Digital Breast Tomosynthesis among Racially/Ethnically Diverse Women Undergoing Screening Mammography

Julia E. McGuinness,Gargi Patel,Jacquelyn N. Amenta,Rita Kukafka,Katherine D. Crew

CANCER RESEARCHno. 5 (2023)

引用0浏览0引用

Dose-finding and -Expansion Studies of Trastuzumab Deruxtecan in Combination with Other Anti-Cancer Agents in Patients (pts) with Advanced/metastatic HER2+(DESTINY-Breast07 [DB-07]) and HER2-low (Destiny-Breast08 [DB-08]) Breast Cancer (BC)

Fabrice Andre,Erika P. Hamilton,Sherene Loi,Seock-Ah Im,Joohyuk Sohn,Ling-Ming Tseng,Carey K. Anders,Peter Schmid,Sarice Boston,Annie Darilay,Pia Maarit Herbolsheimer,Adam Konpa,Gargi Patel,Tinghui Yu,Magdalena Wrona,Komal L. Jhaveri

JOURNAL OF CLINICAL ONCOLOGY（2022）

引用8浏览0引用

Biomarker-Directed Phase II Platform Study in Patients with EGFR Sensitizing Mutation-Positive Advanced/Metastatic Non-Small Cell Lung Cancer Whose Disease Has Progressed on First-Line Osimertinib Therapy (ORCHARD)

Helena A. Yu,Sarah B. Goldberg,Xiuning Le,Zofia Piotrowska,Jonathan W. Goldman,Adrianus J. De Langen,Isamu Okamoto,Byoung Chul Cho,Paul Smith,Ilhem Mensi,Helen Ambrose, Silvija Kraljevic,Julie Maidment,Juliann Chmielecki,Xiaocheng Li-Sucholeiki, Gail Doughton,Gargi Patel, Phil Jewsbury, Phil Szekeres,Jonathan W. Riess

Clinical Lung Cancer（2021）

引用39浏览0WOS引用

Trastuzumab deruxtecan (T-DXd; DS-8201) vs investigator's choice of chemotherapy in patients with hormone receptor-positive (HR+), HER2 low metastatic breast cancer whose disease has progressed on endocrine therapy in the metastatic setting: A randomized, global phase 3 trial (DESTINY-Breast06)

Aditya Bardia,Carlos Barrios,Rebecca Dent,Xichun Hu,Joyce O'Shaughnessy,Kan Yonemori,Annie Darilay,Sarice Boston,Yufan Liu,Gargi Patel,Giuseppe Curigliano

CANCER RESEARCH（2021）

引用7浏览0引用

Abstract OT-03-05: Trastuzumab Deruxtecan (T-Dxd; DS-8201) in Combination with Other Anticancer Agents in Patients with HER2-low Metastatic Breast Cancer: A Phase 1b, Open-Label, Multicenter, Dose-Finding and Dose-Expansion Study (Destiny-Breast08)

Komal Jhaveri,Erika Hamilton,Sherene Loi,Peter Schmid,Annie Darilay,Chen Gao,Gargi Patel,Magdalena Wrona,Fabrice Andre

Cancer Researchno. 4_Supplement (2021): OT-03

引用4浏览0引用

Abstract OT-03-09: Trastuzumab Deruxtecan (T-Dxd; DS-8201) Vs Investigator’s Choice of Chemotherapy in Patients with Hormone Receptor-Positive (HR+), HER2 Low Metastatic Breast Cancer Whose Disease Has Progressed on Endocrine Therapy in the Metastatic Setting: A Randomized, Global Phase 3 Trial (Destiny-Breast06)

Aditya Bardia,Carlos Barrios,Rebecca Dent,Xichun Hu,Joyce O’Shaughnessy,Kan Yonemori,Annie Darilay,Sarice Boston,Yufan Liu,Gargi Patel,Giuseppe Curigliano

Cancer Researchno. 4_Supplement (2021): OT-03

引用13浏览0引用

Protective Role of Estrogen Against Excessive Erythrocytosis in Monge’s Disease

Priti Azad,Francisco C. Villafuerte,Daniela Bermudez,Gargi Patel,Gabriel G. Haddad

The FASEB Journal（2020）

引用32浏览0WOSNATURE引用

A Critical Role for C‐myc in Group 2 Innate Lymphoid Cell Activation

Longyun Ye,Jiexue Pan,Mingwei Liang,Muhammad Asghar Pasha,Xiaofei Shen,Shanti S. D'Souza,Ivan Ting Hin Fung,Yinna Wang,Gargi Patel,Dale D. Tang,Qi Yang

Allergy（2019）

引用23浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn